Because AD is characterized by reduced CSF Aβ42, increased CSF t-Tau, and cognitive impairment, we first analyzed the relationship between DMN connectivity, AD biomarkers (cognitive Z-score, Aβ42, t-Tau), and race to determine when race did not modify the relationship between AD biomarker and connectivity. The gene discussed is MAPT; the disease is Alzheimer disease.